Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Celgene Corp Announces Additional $3.0 Billion Share Repurchase Program


Wednesday, 12 Jun 2013 08:10am EDT 

Celgene Corp announced that Board of Directors authorized the repurchase of up to an additional $3.0 billion of the Company`s common stock. Purchases may be made in the open market or in privately negotiated transactions from time to time, as determined by management and in accordance with applicable requirements of the Securities and Exchange Commission. Year-to-date, Celgene has repurchased approximately $1.8 billion of its common stock and has exhausted the previous $2.5 billion stock repurchase authorization. Celgene has repurchased approximately $6.5 billion of its common stock over the last four years. 

Company Quote

117.18
0.7 +0.60%
19 Dec 2014